175 related articles for article (PubMed ID: 34964774)
1. Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.
Mi JL; Xu M; Liu C; Wang RS
Medicine (Baltimore); 2021 Nov; 100(47):e27947. PubMed ID: 34964774
[TBL] [Abstract][Full Text] [Related]
2. Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.
Fei Z; Qiu X; Li M; Chen C; Li Y; Huang Y
Jpn J Clin Oncol; 2020 Feb; 50(2):159-168. PubMed ID: 31711182
[TBL] [Abstract][Full Text] [Related]
3. Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients.
Zhang LL; Li YY; Hu J; Zhou GQ; Chen L; Li WF; Lin AH; Ma J; Qi ZY; Sun Y
Cancer Res Treat; 2018 Oct; 50(4):1084-1095. PubMed ID: 29141396
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of Web-Based Nomograms to Precisely Predict Survival Outcomes of Non-metastatic Nasopharyngeal Carcinoma in an Endemic Area.
Yao JJ; Lin L; Gao TS; Zhang WJ; Lawrence WR; Ma J; Sun Y
Cancer Res Treat; 2021 Jul; 53(3):657-670. PubMed ID: 33285052
[TBL] [Abstract][Full Text] [Related]
5. Establishment and Validation of a Nomogram for Nasopharyngeal Carcinoma Patients Concerning the Prognostic Effect of Parotid Lymph Node Metastases.
Lin C; Sun XS; Liu SL; Li XY; Lu N; Li XL; Tang LQ; Guo L
Cancer Res Treat; 2020 Jul; 52(3):855-866. PubMed ID: 32164051
[TBL] [Abstract][Full Text] [Related]
6. The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Wan Y; Tian L; Zhang G; Xin H; Li H; Dong A; Liang Y; Jing B; Zhou J; Cui C; Chen M; Sun Y; Xie C; Liu L; Shao Y
Radiother Oncol; 2019 Feb; 131():35-44. PubMed ID: 30773185
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
Jiang Y; Qu S; Pan X; Huang S; Zhu X
Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
[TBL] [Abstract][Full Text] [Related]
8. MRI-detected residual retropharyngeal lymph node after intensity-modulated radiotherapy in nasopharyngeal carcinoma: Prognostic value and a nomogram for the pretherapy prediction of it.
Li WZ; Liu GY; Lin LF; Lv SH; Qiang MY; Lv X; Wu YS; Liang H; Ke LR; Wang DL; Yu YH; Qiu WZ; Liu KY; Guo X; Li JP; Zou YJ; Xiang YQ; Xia WX
Radiother Oncol; 2020 Apr; 145():101-108. PubMed ID: 31931288
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
Wu S; Xia B; Han F; Xie R; Song T; Lu L; Yu W; Deng X; He Q; Zhao C; Xie C
PLoS One; 2015; 10(8):e0134491. PubMed ID: 26248338
[TBL] [Abstract][Full Text] [Related]
10. A nomogram based on nutritional and inflammatory parameters to predict DMFS and identify beneficiaries of adjuvant chemotherapy in IVA-stage nasopharyngeal carcinoma.
Pan Y; Chen Z; Hong W; Huang Z; Li Y; Cai S; Lai J; Lu J; Qiu S
BMC Cancer; 2024 May; 24(1):578. PubMed ID: 38734620
[TBL] [Abstract][Full Text] [Related]
11. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
[TBL] [Abstract][Full Text] [Related]
12. Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
Yang H; Zhang R; Zhang R; Zhang B; Xie Y; Qin G; Mo Y; Ruan X; Jiang W
Strahlenther Onkol; 2022 Sep; 198(9):828-837. PubMed ID: 35384452
[TBL] [Abstract][Full Text] [Related]
13. Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis.
Huang XD; Zhou GQ; Lv JW; Zhou HQ; Zhong CW; Wu CF; Zheng ZQ; He XJ; Peng L; Ma J; Sun Y
Radiother Oncol; 2018 Nov; 129(2):389-395. PubMed ID: 30270098
[TBL] [Abstract][Full Text] [Related]
14. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
Huang YY; Zhou JY; Zhan ZJ; Ke LR; Xia WX; Cao X; Cai ZC; Deng Y; Chen X; Zhang LL; Huang HY; Guo X; Lv X
BMC Cancer; 2023 May; 23(1):410. PubMed ID: 37149594
[TBL] [Abstract][Full Text] [Related]
15. Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.
Zeng L; Guo P; Li JG; Han F; Li Q; Lu Y; Deng XW; Zhang QY; Lu TX
Oncotarget; 2015 Nov; 6(36):39373-83. PubMed ID: 26415223
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era.
Niu X; Xue F; Liu P; Hu C; He X
Int J Med Sci; 2022; 19(2):267-273. PubMed ID: 35165512
[No Abstract] [Full Text] [Related]
18. Development and validation of a nomogram for predicting the survival of patients with non-metastatic nasopharyngeal carcinoma after curative treatment.
Liang W; Shen G; Zhang Y; Chen G; Wu X; Li Y; Li A; Kang S; Yuan X; Hou X; Huang P; Huang Y; Zhao H; Tian Y; Zhao C; Zhang L
Chin J Cancer; 2016 Nov; 35(1):98. PubMed ID: 27887636
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.
Yang XL; Wang Y; Liang SB; He SS; Chen DM; Chen HY; Lu LX; Chen Y
BMC Cancer; 2018 May; 18(1):606. PubMed ID: 29843648
[TBL] [Abstract][Full Text] [Related]
20. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Feng M; Wang W; Fan Z; Fu B; Li J; Zhang S; Lang J
Radiat Oncol; 2013 Sep; 8():208. PubMed ID: 24007375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
